These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 29681373

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of recombinant human granulocyte-colony stimulating factor on neutropenic mice infected with Candida albicans: acceleration of recovery from neutropenia and potentiation of anti-C. albicans resistance.
    Hamood M, Bluche PF, De Vroey C, Corazza F, Bujan W, Fondu P.
    Mycoses; 1994; 37(3-4):93-9. PubMed ID: 7531290
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Recent knowledge allowing diagnosis and treatment of deep-seated trichosporonosis].
    Yamakami Y, Yamagata E, Karashima R, Tokimatsu I, Kamberi P, Hashimoto A, Nagai H, Nasu M.
    Nihon Ishinkin Gakkai Zasshi; 2000; 41(4):235-9. PubMed ID: 11064321
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Recombinant human granulocyte colony-stimulating factor improves the compromised state of recipient mice without affecting the induction of specific tolerance in the cyclophosphamide-induced tolerance system.
    Nishimura Y, Mayumi H, Tomita Y, Eto M, Maeda T, Nomoto K.
    J Immunol; 1991 Apr 15; 146(8):2639-47. PubMed ID: 1707914
    [Abstract] [Full Text] [Related]

  • 9. Experimental study on safety for granulopoiesis in simultaneous therapy with recombinant human granulocyte colony-stimulating factor and chemotherapy.
    Kabaya K, Obuchi M, Watanabe M, Kusaka M, Seki M.
    Oncol Res; 1995 Apr 15; 7(3-4):165-71. PubMed ID: 8555650
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A synergistic increase in transplantable peripheral blood stem cells in mice by co-administration of recombinant human interleukin 6 and recombinant human granulocyte colony-stimulating factor.
    Suzuki H, Okano A, Suzuki C, Konishi A, Akiyama Y, Ishibashi T, Ozawa K, Asano S.
    Transplantation; 1995 Jun 15; 59(11):1596-600. PubMed ID: 7539959
    [Abstract] [Full Text] [Related]

  • 13. [Significance of donors treatment with combination of recombinant human interleukin-11 and recombinant human granulocyte-colony stimulating factor in reduction of incidence of lethal grafts versus host disease after allogeneic bone marrow transplantation].
    Zhao J, Zhao XY, Huang XJ.
    Zhonghua Yi Xue Za Zhi; 2005 Sep 14; 85(35):2497-502. PubMed ID: 16321278
    [Abstract] [Full Text] [Related]

  • 14. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
    Iguchi K, Inoue S, Kumar A.
    Exp Hematol; 1991 Jun 14; 19(5):352-8. PubMed ID: 1709109
    [Abstract] [Full Text] [Related]

  • 15. Protective effect of recombinant human granulocyte colony-stimulating factor against pneumococcal infections in splenectomized mice.
    Hebert JC, O'Reilly M, Gamelli RL.
    Arch Surg; 1990 Aug 14; 125(8):1075-8. PubMed ID: 1696096
    [Abstract] [Full Text] [Related]

  • 16. In vivo effects of recombinant human granulocyte colony-stimulating factor on normal neutrophil function and membrane effector molecule expression.
    Itoh Y, Kuratsuji T, Tsunawaki S, Aizawa S, Toyama K.
    Int J Hematol; 1991 Dec 14; 54(6):463-9. PubMed ID: 1724390
    [Abstract] [Full Text] [Related]

  • 17. Adjunctive efficacy of granulocyte colony-stimulating factor on treatment of Pseudomonas aeruginosa pneumonia in neutropenic and non-neutropenic hosts.
    Babalola CP, Nightingale CH, Nicolau DP.
    J Antimicrob Chemother; 2004 Jun 14; 53(6):1098-100. PubMed ID: 15128727
    [Abstract] [Full Text] [Related]

  • 18. The prophylactic effectiveness of various antifungal agents against the progression of trichosporonosis fungemia to disseminated disease in a neutropenic mouse model.
    Tokimatsu I, Kushima H, Hashinaga K, Umeki K, Ohama M, Ishii H, Kishi K, Hiramatsu K, Kadota J.
    Int J Antimicrob Agents; 2007 Jan 14; 29(1):84-8. PubMed ID: 17189098
    [Abstract] [Full Text] [Related]

  • 19. Synergistic effects of pegylated recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor on mobilization of hematopoietic progenitor and stem cells with long-term repopulating ability into peripheral blood in mice.
    Honda K, Takenaka K, Shinagawa K, Ishimaru F, Ikeda K, Niiya K, Harada M.
    Bone Marrow Transplant; 2001 Aug 14; 28(4):329-34. PubMed ID: 11571503
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.